SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML
Product details
Registration number: SIN16883P
Classification: Prescription Only
Active ingredients: Spesolimab
Strength: 450 mg/7.5ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: L04AC22
HSA approval date: 12 October 2023
Manufacturer(s): Boehringer Ingelheim Pharma GmbH & Co. KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16883P
Classification: Prescription Only
What active ingredients and strength are recorded for SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Spesolimab
Strength: 450 mg/7.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Boehringer Ingelheim Pharma GmbH & Co. KG
Manufacturing country/countries: GERMANY
Where can I look up SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16883P or the exact product name SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML. The general register link does not preselect this product.
What are the source dates for this SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16883P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)